Funder
National Institute for Medical Research Development
Shiraz University of Medical Sciences
Reference63 articles.
1. Preclinical evaluation of SCC244 (Glumetinib), a novel, potent, and highly selective inhibitor of c-Met in MET-dependent cancer models;Ai;Mol. Canc. Therapeut.,2018
2. Olive phenolics as c-Met inhibitors:(-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models;Akl;PloS One,2014
3. Capmatinib (INC280) is active against models of non–small cell lung cancer and other cancer types with defined mechanisms of MET activation;Baltschukat;Clin. Canc. Res.,2019
4. Intorno ad uramidi aldeidiche dell’etere acetilacetico;Biginelli;Gazz. Chim. Ital.,1891
5. Aldehyde-urea derivatives of aceto- and oxaloacetic acids;Biginelli;Gazz. Chim. Ital.,1893
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献